ES2177672T3 - Procedimiento para preparacion de lamotrigina. - Google Patents

Procedimiento para preparacion de lamotrigina.

Info

Publication number
ES2177672T3
ES2177672T3 ES95941817T ES95941817T ES2177672T3 ES 2177672 T3 ES2177672 T3 ES 2177672T3 ES 95941817 T ES95941817 T ES 95941817T ES 95941817 T ES95941817 T ES 95941817T ES 2177672 T3 ES2177672 T3 ES 2177672T3
Authority
ES
Spain
Prior art keywords
lamotrigin
procedure
preparation
formula
conh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95941817T
Other languages
English (en)
Inventor
Raymond Geoffrey Winter
David Alan Sawyer
Andrew Germain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9426439A external-priority patent/GB9426439D0/en
Priority claimed from GB9426447A external-priority patent/GB9426447D0/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of ES2177672T3 publication Critical patent/ES2177672T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

LA INVENCION PROPORCIONA UN PROCEDIMIENTO DE PRODUCCION DE LAMOTRIGINA DE FORMULA (I) QUE CONSISTE EN SOMETER UN COMPUESTO DE FORMULA (II), DONDE R ES CN O CONH{SUB,2}, EN UN DISOLVENTE ORGANICO, A RADIACION ULTRAVIOLETA O VISIBLE Y, CUANDO R ES CN, AL CALOR.
ES95941817T 1994-12-30 1995-12-29 Procedimiento para preparacion de lamotrigina. Expired - Lifetime ES2177672T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9426439A GB9426439D0 (en) 1994-12-30 1994-12-30 Process
GB9426447A GB9426447D0 (en) 1994-12-30 1994-12-30 Process

Publications (1)

Publication Number Publication Date
ES2177672T3 true ES2177672T3 (es) 2002-12-16

Family

ID=26306284

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95941817T Expired - Lifetime ES2177672T3 (es) 1994-12-30 1995-12-29 Procedimiento para preparacion de lamotrigina.

Country Status (13)

Country Link
US (1) US5912345A (es)
EP (1) EP0800520B1 (es)
JP (1) JPH11501007A (es)
AT (1) ATE219487T1 (es)
AU (1) AU4311596A (es)
DE (1) DE69527153T2 (es)
DK (1) DK0800520T3 (es)
ES (1) ES2177672T3 (es)
FI (1) FI972719A7 (es)
HU (1) HU224688B1 (es)
PT (1) PT800520E (es)
RU (1) RU2145602C1 (es)
WO (1) WO1996020934A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420354B1 (en) 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
GB9812413D0 (en) * 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
AU763244B2 (en) * 2000-01-03 2003-07-17 Rpg Life Sciences Limited A process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
DE10134980C2 (de) * 2001-07-17 2003-05-28 Helm Ag Verfahren zur Herstellung von Lamotrigin
CA2366521C (en) 2001-12-24 2007-03-06 Brantford Chemicals Inc. A new and efficient process for the preparation of lamotrigine and related 3,5-diamino-6-substituted-1,2,4-triazines
HU225667B1 (en) * 2002-09-20 2007-05-29 Richter Gedeon Nyrt Method for producing high-purity 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
US20120142919A1 (en) 2006-08-02 2012-06-07 Medichem, S.A. Method for synthesizing lamotrigine
WO2009061513A1 (en) * 2007-11-09 2009-05-14 Thar Pharmaceuticals Crystalline forms of lamotrigine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
AR227521A1 (es) * 1979-06-01 1982-11-15 Wellcome Found Procedimiento para la preparacion de derivados de 3,5-diamino-6-(fenil substituido)-1,2,4-triazinas e intermediario para realizar el procedimiento
EP0150677B1 (de) * 1984-01-11 1989-01-18 Ciba-Geigy Ag Herbizide und insektizide Triazinone
ATE39478T1 (de) * 1984-05-29 1989-01-15 Ciba Geigy Ag Verfahren zur herstellung von alphachloracetessigs|uremonomethylamid.
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9203483D0 (en) * 1992-02-19 1992-04-08 Wellcome Found Anti-inflammatory compounds

Also Published As

Publication number Publication date
AU4311596A (en) 1996-07-24
JPH11501007A (ja) 1999-01-26
FI972719A0 (fi) 1997-06-24
HU224688B1 (hu) 2005-12-28
DE69527153D1 (de) 2002-07-25
HUT77346A (hu) 1998-03-30
DK0800520T3 (da) 2002-10-14
RU2145602C1 (ru) 2000-02-20
PT800520E (pt) 2002-11-29
EP0800520B1 (en) 2002-06-19
EP0800520A1 (en) 1997-10-15
DE69527153T2 (de) 2002-12-19
ATE219487T1 (de) 2002-07-15
FI972719L (fi) 1997-08-27
FI972719A7 (fi) 1997-08-27
US5912345A (en) 1999-06-15
WO1996020934A1 (en) 1996-07-11

Similar Documents

Publication Publication Date Title
BR9302680A (pt) Processo para hidroformilacao para produzir 1,6-hexanodiais
ES2195970T3 (es) L-ribavirina y usos de la misma.
NO944430L (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
BR9205142A (pt) Composicao inseticida,e,processo para produzi-la
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
BR9104455A (pt) Processo para deslignificacao de polpa com oxigenio,processo para deslignificacao e alvejamento de polpa e polpa
BR9301552A (pt) Composicao desinfetante concentrada,composicao desinfetante aquosa e processo para desinfetar uma superficie ou um artigo
ES2063097T3 (es) Inhibidor de la glicosidasa salbostatina, procedimiento para su preparacion y su empleo.
BR9006957A (pt) Processo para alvejamento com cloretos organicos reduzidos
FI913833A7 (fi) Rengassubstituoidut 2-amino-1,2,3,4-tetrahydronaftaleenit, 3-aminokromaanit ja aminotiokromaanit
PT97796A (pt) Processo para a preparacao de piperidinas substituidas
ATE127791T1 (de) Quinolin-3-carboxanilid-derivate.
ES2177672T3 (es) Procedimiento para preparacion de lamotrigina.
ES2156120T3 (es) Derivados arilamidicos.
FI920526A7 (fi) Rengassubstituoidut 2-amino-1,2,3,4-tetrahydronaftaleenit ja 3-aminokromaanit
MX9304399A (es) Proceso novedoso para preparar [[2-bromoetil)-amino]metil]-2-nitro-1h-imidazol-1-etanol quiral y compuestos relacionados.
ES2171722T3 (es) Nuevos derivados de la 5-o-desosaminil-6-o-metil-eritronolida a, su procedimiento de preparacion y su aplicacion a la preparacion de productos biologicamente activos.
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
PT545511E (pt) Processo para a preparacao de tetraazamacrociclos mono-n-substituidos
PT99756A (pt) Processo para a preparacao de 2-aril-5-(trifluorometil)pirroles uteis como agentes pesticidas e como intermediarios para a preparacao dos referidos agentes
ES2012736A6 (es) Procedimiento para la preparacion de derivados triciclicos de 3-oxopropanonitrilo.
BR9304780A (pt) Composto, processo para preparar o composto, composição farmacêutica e uso
ES2126798T3 (es) Procedimiento de preparacion de anhidrido tetrafluoroftalico.
PT98268A (pt) Processo para a preparacao de indano-pirrolidino-carbamatos
BR9807785A (pt) Processo para a preparação do composto, e, composto